Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
3(27%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
9
82%
Ph phase_4
2
18%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (18.2%)
N/A9 (81.8%)

Trials by Status

terminated19%
recruiting327%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11